ChemistryView: how Pfizer simplifies its legacy desktop chemistry systems
David introduces ChemistryView, Pfizer’s custom developed Java component designed to simplify their legacy chemistry software systems. ChemistryView stemmed from a strong desire for the company’s often 20-years old applications to be user customizable and to have consistent tools for managing advanced stereochemistry.
Advocating Change: One Synthetic Cannabinoid at a Time
Zofia talks about how compliance aspects associated with sample management are becoming more critical due to the collaborative and globally distributed nature of research. She showcases it through her experience working with the industry and authorities to modify the Third Generation Synthetic Cannabinoids amendment.
Generative AI Begins to Dominate the AI Conversation in Early Drug Discovery
In his presentation, Joe focuses on how deep neural networks and generative AI are transforming molecular design, improving predictions, and enhancing the drug discovery process.